Education Experience
| -1982 | B.Sc. Pharmacy | Fudan University |
| -1993 | Ph. D. Clinical Pharmacology and Biopharmaceutics | University of Connecticut |
Professional Experience
| 1982-1986 | Lecturer | Suzhou University |
| 1986-1989 | Visiting scholar | University of Connecticut |
| 1993-2005 | highest ranked Expert Scientists / Reviewer | U.S. Food and Drug Administration |
| 2006- | Vice president/Chairman | Tasly Holding Group Co., Ltd. |
| 2015- | Director | State Key Laboratory of Core Technology in Innovative Chinese Medicine. |
Research Area
Honors and Awards
| Senior Fellow, Professor, Chinese Academy of Sciences |
| Deputy Director at the Center for Integrative Medicine, Columbia University, New York, NY. |
| Special Prof., University of Nottingham, UK |
| Vice Chairman, Board of Directors, Transgene-Tasly (Tianjin) Bio-pharmaceuticals, Co. Ltd. (French) |
| Vice Chairman, Board of Directors, Cardiox Inc. CA. (USA) |
| CEO, Axeon Biomedicine Globalization Co., Ltd. (China and USA) |
| General Secretary, Traditional Chinese Medicine Globalization Alliance (Hong Kong) |
| CEO, Deepure, Inc. (USA) |
| CEO, NatureKue, Inc. (USA) |
| 2015 Qihuang International Award, World Association of Chinese Medicine, UK |
| 2011 Life-time Distinguished Achievement Award, Tasly Holding Group, Co. Ltd., Worldwide. |
| 2009 Named the Life-time Outstanding National Professor, The Highest Ranking Professor in China, Ministry of Science and Technology, China |
| 1998 FDA Commendable Service Award from the Commissioner, FDA, USA |
| 1997 FDA Commendable Service Award from the Commissioner, FDA, USA |
| 2005 FDA Frances O. Kelsey Drug Safety Excellence Award, Federal Government, USA |
| 2000 Center Directors Special Citation Award, CDER, FDA |
Patents
| A kind of ascaridol gastric retention preparation and its preparation method. 2009.3.6 |
| A detection method of traditional Chinese medicine products. 2009.04.20 |
| The concentration-time curve prediction model of Fluoroquinolones based on physicochemical properties. 2011.10.31 |
| Capsule of compound Danshen dripping pills. 2010.2.23 |
| Capsule of compound Danshen dripping pills. 2012.6.5 |
| The use of a Salvia miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease. 2011.8.8 |
| 1H-NMR fingerprints of Compound Danshen Dripping Pills. 2013.07.15 |
| The concentration-time curve prediction model of Statin drug based on physicochemical properties. 2013.7.1 |
Highlighted Publications
| Xinwen Zhang, Wenyue Liu, Guizhi Xiao, He Sun. A hypoxia-inducible factor prolyl hydroxylase inhibitor: roxadustat. Drugs & Clinic. 2016，4(31). |
| Ruizhi Luo, Libin Zhao, Zhixin Guo, He Sun. Insight into recently issued community herbal monograph on Ginkgo biloba L., folium and its impact on registration strategy of Ginkgo Folium products in EU. Chinese Traditional and Herbal Drugs, 2015, 46(13). |
| Wangjing Sun, Jing Wu, He Sun. The Application of PDCA In Adverse Drug Reaction and Adverse Event Management. Journal of China Prescription Drug. 2015, 01. |
| Shasha Hao, He Sun, Xiaohui Ma, Jing Wei. Methodology on the no Washout Period Bioequivalence of Long Half-life Drugs*. Progress in Modern Biomedicine.2014, 14(2). |
| Qilin Shi，Xiaohui Ma，Lulu Yan, Xiaojie Xu, He Sun. Network pharmacological studies of Huoxiang Zhengqi pill in treating functional dyspepsia. Chinese Journal of New Drugs. 2014, 23(12). |
| Pengli Jiang, Jing Wu, He Sun. Association of cognitive decline, diabetes mellitus and cancer with statins use: gaining insight through the FDA pharmacovigilance database. Chinese Journal of Clinical Pharmacology and Therapeutics. 2014, 19(10). |
| Qiuyu Chen, Yonghong Zhu, Libin Zhao, Yi He, Ning Wang, Zhi-xin Guo, He Sun. Application and practice for e-submission of drug registration in EU. Drug Evaluation Research. 2014, 37(5). |
| Zhihua Yue, Pengli Jiang, He Sun, Jing Wu. Association between an excess risk of acute kidney injury and concomitant use of ibuprofen and acetaminophen in children, retrospective analysis of a spontaneous reporting system. European Journal of Clinical Pharmacology, 70(4), pp 479-482, 2014/4. |
| Jing Wu, Yuerong Han, Judy Xu, Yang Lu, Hongliang Cong, Junyi Zheng, He Sun. Chronic Stable Angina Is Associated with Lower Health-Related Quality of Life: Evidence from Chinese Patients, PLos One, 9(5), 2014/5/19. |
| H, Li, He Sun. The historical evolution of china's drug regulatory system, pp A30-A31, 2014/5. |
| Ping Wang, He Sun, Liu Yang, Ling Yan Li, Jing Hao, Dennis Ruff, Zhixin Guo. Absence of an Effect of T89 on the Steady-State Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Volunteers. journal of clinical pharmacology, 54(2), pp 234-239, 2014/2. |
| Luqian Wang, Xu Wang, Ling Tong, Xiaowen Li, Wenyuan Liu, Shuiping Zhou, He Sun. Establishment of UPLC-PDA-ELSD fingerprints of Xiaokeqing Granules and determination of its five main constituents, Chinese Traditional and Herbal Drugs, 2013, 44 (24). |
| Genbei Wang, Jing Cao, Xiaohui Ma, Zhiwen Li, Ruizhi Luo, Zhixin Guo, He Sun. Requirements of FDA for preclinical toxicological studies on preparation of phytomedicine in US, Chinese Traditional and Herbal Drugs, 2013, 44(1). |